Scarica l'app Stockscreener
1.985
1.50%
-0.015
Precedente Chiudi:
$2.00
Aprire:
$2.02
Volume 24 ore:
12,561
Relative Volume:
0.06
Capitalizzazione di mercato:
$64.31M
Reddito:
-
Utile/perdita netta:
$-13.20M
Rapporto P/E:
-3.3045
EPS:
-0.6007
Flusso di cassa netto:
$-12.14M
1 W Prestazione:
-1.99%
1M Prestazione:
-20.56%
6M Prestazione:
-1.01%
1 anno Prestazione:
-37.26%
Intervallo 1D:
$1.98
$2.02
Intervallo di 1 settimana:
$1.95
$2.10
Portata 52W:
$1.53
$4.90
Monogram Technologies Inc Stock (MGRM) Company Profile
Nome
Monogram Technologies Inc
Settore
Industria
Telefono
(718) 576-3205
Indirizzo
53 BRIDGE STREET UNIT 507, BROOKLYN
Confronta MGRM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| MGRM | 2.00 | 64.31M | 0 | -13.20M | -12.14M | -0.6007 |
| ABT | 115.65 | 201.34B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 387.61 | 146.32B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 91.02 | 132.22B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.64 | 107.39B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 69.94 | 41.01B | 6.60B | 4.16B | 490.10M | 2.34 |
Monogram Technologies Inc Borsa (MGRM) Ultime notizie
Giraffes are up next on the endangered species list, US wildlife officials say - WSIL TV
Madrigal Pharmaceuticals Engages with Investors at Key Conferences - MSN
Ormat Technologies Q3 Earnings Beat Estimates, Revenues Rise Y/Y - MSN
Orthopedic Surgical Robotics Market Insights 2024: Growth, Innovations, and Forecast - WhaTech
Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely? - Yahoo Finance
Monogram Orthopaedics (MGRM) Set to Announce Quarterly Earnings on Tuesday - Defense World
Monogram Technologies Inc. (MGRM) Quarterly 10-Q Report - Quartzy
Monogram Orthopaedics Advances with FDA Filing and Partnerships - TipRanks
Monogram Technologies Reports Third Quarter 2024 Financial Results - StockTitan
Monogram Tech (MGRM) Sets Q3 Earnings Call: AI Robotics Leader to Share Surgery Tech Updates | MGRM Stock News - StockTitan
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024 - GuruFocus.com
SEC Form PRE 14A filed by Monogram Technologies Inc. - Quantisnow
Monogram Orthopaedics Wins 2024 Orthopedic Company Award - TipRanks
Orthopedic Joint Replacement Robots - Trend Hunter
Short Interest in Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Declines By 40.0% - MarketBeat
Profiles of Super Women in Business 2024 honorees - The Business Journals
MGRMMonogram Technologies Inc. Latest Stock News & Market Updates - StockTitan
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024 - StockTitan
Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Update - MarketBeat
Monogram Orthopaedics (NASDAQ:MGRM) Shares Up 1.7% – Here’s Why - Defense World
Monogram Orthopaedics (NASDAQ:MGRM) Trading Up 1.7%Here's Why - MarketBeat
HR Impact Awards honoree: Ana Rodriguez of Monogram Foods - The Business Journals
Elevated Entertaining: Monogram Appliances and Chef Patrick Kriss Showcase Culinary Excellence at Holts Café Across Canada - Yahoo Finance
Monogram Orthopaedics Clarifies FDA Response Timeline - TipRanks
Monogram Technologies : Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System (Correction Notice) Form 8 K - Marketscreener.com
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System - StockTitan
Monogram Technologies Receives FDA Response for mBôs TKA System - Milton Daily Standard
Monogram Technologies Inc. Receives FDA Response for Mbôs Tka System - Marketscreener.com
Monogram Orthopaedics Secures Funding and Pursues FDA Approval - TipRanks
Monogram Technologies : Announces Closing of Upsized and Oversubscribed $13 Million Public Offering Form 8 K - Marketscreener.com
Monogram Technologies Announces Preferred Stock Dividends - StockTitan
Monogram Orthopaedics Announces Quarterly Preferred Dividend - TipRanks
Monogram Technologies : Announces Preferred Stock Dividends Form 8 K - Marketscreener.com
Monogram Health inks direct lease for long-term Tempe Town Lake office - The Business Journals
Should investors be concerned about Monogram Technologies Inc. (MGRM)? - US Post News
Monogram Technologies Inc. (MGRM) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Stock Performance Spotlight: Monogram Technologies Inc. (MGRM) Ends the Day at 2.84, Down by -12.35 - The Dwinnex
Granite Point Mortgage Trust Inc (GPMT)’s financial ratios: A comprehensive overview - The Dwinnex
Gorilla Technology completes share buyback, eyes future growth By Investing.com - Investing.com Australia
Gorilla Technology Completes Purchase of 1.1 Million Shares, Accelerates Buyback Programme to Capitalise on Substantial Undervaluation - Taiwan News
Highbridge Capital Management LLC Acquires Shares of 173,289 Gorilla Technology Group Inc. (NASDAQ:GRRR) - Defense World
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI) - MarketBeat
After-hours movers: Intuitive Machines, Casella Waste Systems, Galmed Pharma, Edgewise Therapeutics - Investing.com Australia
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 5.8% - MarketBeat
Gorilla Announces Share Buyback of Up To $6 Million as It Deems Shares To Be Undervalued - GlobeNewswire
Savant Partners with Monogram Appliances for the CI Channel - Residential Tech Today
Monogram Technologies Inc. (MGRM) is a good investment, but the stock may be overvalued - US Post News
Monogram Orthopaedics Expands Offering for Corporate Growth - TipRanks
Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million - StockTitan
SEC Form 424B5 filed by Monogram Technologies Inc. - Quantisnow
Begrudging acceptance - Morning Brew
Monogram Technologies Inc Azioni (MGRM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.02%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):